Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 3 pseudogene 32 (HMGB3P32) is classified as a pseudogene in the human genome, related to the functional gene High mobility group box 3 (HMGB3)[1][3][12]. Pseudogenes are gene sequences that resemble known genes but contain mutations or truncations that prevent them from producing functional proteins[1][12]. There is no evidence that HMGB3P32 encodes a functional protein, nor is it involved in biological pathways, disease mechanisms, or considered a drug target. It is best described as a nonfunctional genomic element, serving potentially as a marker for genetic studies but not as a molecular or therapeutic target[1][9][12].
None (no drugs target this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 3 pseudogene 32 (HMGB3P32).